| pubmed-article:19013107 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:19013107 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:19013107 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19013107 | pubmed:dateCreated | 2008-11-28 | lld:pubmed |
| pubmed-article:19013107 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:abstractText | Platinum-containing two-drug combinations improve survival and cancer-related symptoms in patients with advanced non-small-cell lung cancer (NSCLC). However, survival benefit is modest and platinum-containing regimens cause substantial toxic effects. We did a prospective randomised open-label phase III study to compare an experimental platinum-free, triplet, sequential regimen of vinorelbine plus gemcitabine followed by docetaxel with the standard platinum-containing, doublet regimen paclitaxel plus carboplatin in patients with advanced NSCLC. | lld:pubmed |
| pubmed-article:19013107 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19013107 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19013107 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19013107 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19013107 | pubmed:issn | 1474-5488 | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:NishiwakiYuta... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:KawaharaMasaa... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:KubotaKaoruK | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:OgawaraMitsum... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:TeramukaiSato... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:KomutaKiyoshi... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:FuruseKiyoyuk... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:FukushimaMasa... | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:FujitaYukaY | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:MinatoKoichiK | lld:pubmed |
| pubmed-article:19013107 | pubmed:author | pubmed-author:Japan... | lld:pubmed |
| pubmed-article:19013107 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19013107 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:19013107 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19013107 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19013107 | pubmed:pagination | 1135-42 | lld:pubmed |
| pubmed-article:19013107 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:meshHeading | pubmed-meshheading:19013107... | lld:pubmed |
| pubmed-article:19013107 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19013107 | pubmed:articleTitle | Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. | lld:pubmed |
| pubmed-article:19013107 | pubmed:affiliation | National Cancer Centre Hospital East, Kashiwa, Chiba, Japan. | lld:pubmed |
| pubmed-article:19013107 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19013107 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19013107 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19013107 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19013107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19013107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19013107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19013107 | lld:pubmed |
